Can apps keep transplant patients healthy? new study tests digital lifestyle coaching
NCT ID NCT07305012
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a doctor-led counseling program, combined with two smartphone apps (Nutrida and Gamebus), can help older adults (60+) who have had a liver or kidney transplant eat better and be more active. Sixty participants will first receive lifestyle advice, then use the apps for 12 weeks. Researchers will check if people stick with the program and if it improves their diet, activity levels, and health measures.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Digital support tools (Nutrida and Gamebus apps) plus lifestyle counseling
- What this could lead to
- If successful, this could show that smartphone apps are a practical way to help older transplant recipients adopt healthier habits, potentially improving their long-term health.
- What could go wrong
- This is a small, early feasibility study with only 60 participants and no control group. The apps may not be easy for all older adults to use, and any health improvements may be modest or not last.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 60 years * Liver or kidney transplant received at least 6 months and no more than 25 years prior * BMI between 21 and 29.9 * Signed informed consent * Having a personal smartphone * Stable immunosuppressive therapy in the past 3 months Exclusion Criteria: * Significant weight change (\>5% of body weight) in the past 3 months * Combined liver-kidney transplant * Medical conditions requiring specific diets that may render adherence to the dietary recommendations of the trial unsafe (e.g., chronic kidney disease, inflammatory bowel disease, celiac disease, bariatric surgery, etc.) * General physical conditions deemed by the investigator to contraindicate safe participation in any of the trial activities (e.g., blindness, vertebral fractures, wheelchair dependence, home oxygen therapy, etc.) * Adherence to specific dietary regimens for ethical and/or religious reasons that are incompatible with the dietary recommendations of this trial * Active malignant tumors currently under pharmacological treatment or awaiting surgical treatment (except cutaneous squamous cell carcinomas), or history of malignant tumors within the last 5 years, except for hepatocellular carcinoma * Psychiatric comorbidities deemed by the investigator to potentially compromise safety and/or adherence, thereby risking biasing the results (e.g., schizophrenia, bipolar disorder, eating disorders, etc.) * Changes in glucose-lowering or lipid-lowering therapy during the 90 days prior to the enrollment visit * Active participation in another research or non-research program aimed at lifestyle modification * Any clinical condition, diagnosed or under diagnostic evaluation, that the investigator considers may compromise safety and/or a priori adherence to the intervention, with a potential risk of altering the study outcomes
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kidney transplant are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITINGBologna, BO, 40138, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new tool aims to predict and prevent living kidney donor Drop-Out
- Can digital tools and training help more kidney patients get transplants?
- Can a new preservation fluid keep donor kidneys healthier for transplant?
- Could organs from HIV-Positive donors be safe for recipients with HIV?
- Oxygen bath for donor kidneys: a new hope for transplant success?
- Could smarter scores save lives on the liver transplant waitlist?